Seven in 10 DSM-5 panel members has financial ties to drug companies. March 13, 2012— -- Controversy continues to swell around the fifth edition of the Diagnostic and Statistical Manual of Mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback